# Egg Protein Hydrolysate and Vascular Function

> **NCT01559896** · NA · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 40 (actual)

## Conditions studied

- Arterial Stiffness
- Dietary Modification
- Impaired Glucose Tolerance
- Type 2 Diabetes Mellitus

## Interventions

- **DIETARY_SUPPLEMENT:** protein hydrolysate capsules and placebo capsules

## Key facts

- **NCT ID:** NCT01559896
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-05
- **Final completion:** 2013-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2014-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01559896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01559896, "Egg Protein Hydrolysate and Vascular Function". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01559896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
